Showing 1 - 20 results of 5,307 for search '(( three ((we decrease) OR (nn decrease)) ) OR ( ai ((larger decrease) OR (marked decrease)) ))', query time: 0.40s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Overview of the WeARTolerance program. by Ana Beato (20489933)

    Published 2024
    “…This research evaluates the "WeARTolerance’’ arts-based program in reducing mental health stigma among diverse youths. …”
  6. 6
  7. 7
  8. 8

    Application of WeChat-based cognitive behavioural stress management for early-stage cervical cancer patients: a randomised controlled study by Qing Hao (566198)

    Published 2024
    “…WB-CBSM decreased anxiety scores at month (M) 1, M3, and M6; it also reduced depression scores at M3 and M6 compared with NC. …”
  9. 9

    Image 3_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif by Ying Ye (72583)

    Published 2025
    “…</p>Methods<p>In this study, we applied the HuProt array and the bioinformatics analysis to assess the diagnostic values of the decreased autoantibodies in lung cancers.…”
  10. 10
  11. 11
  12. 12

    Data Sheet 1_The good, the bad, and the unknown nature of decreased GD3 synthase expression.pdf by Borna Puljko (20311620)

    Published 2024
    “…<p>This paper explores the physiological consequences of decreased expression of GD3 synthase (GD3S), a biosynthetic enzyme that catalyzes the synthesis of b-series gangliosides. …”
  13. 13

    Expanding Three-Coordinate Gold(I) Anticancer Agent Chemical Space by Charles E. Greif (21728091)

    Published 2025
    “…We report the synthesis and characterization of 14 complexes of the type (Au(R)[N̂N])<sup>+</sup>, where R = tunable biaryldialkyl phosphine ligands and [N̂N] = bidentate phenanthroline derivatives as anticancer agents. …”
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…”